NCI Plans $38 Million for Research on Smoking Prevention

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 9
Volume 7
Issue 9

BETHESDA, Md--With tobacco legislation stalled on Capitol Hill, Vice President Gore preached the antismoking gospel at a cathedral of the committed--the National Institutes of Health--where he urged Congress to pass a comprehensive tobacco bill and announced that the National Cancer Institute plans to allocate an additional $38 million for research on smoking prevention and cessation programs.

BETHESDA, Md--With tobacco legislation stalled on Capitol Hill, Vice President Gore preached the antismoking gospel at a cathedral of the committed--the National Institutes of Health--where he urged Congress to pass a comprehensive tobacco bill and announced that the National Cancer Institute plans to allocate an additional $38 million for research on smoking prevention and cessation programs.

The research funds are part of NCI’s fiscal year 1999 budget, which has yet to pass Congress. The institute will spend the money over 2 years.

"These investments in more research can help turn the tide of the tobacco epidemic," Mr. Gore said. "By funding groundbreaking new tobacco research, we will harness the full power of science and technology to protect our children."

The vice president spoke to some 600 attendees at a conference on nicotine addiction sponsored by NIH, the National Institute on Drug Abuse (NIDA), and the Robert Wood Johnson Foundation.

According to the White House, the NCI-funded research efforts will:

Determine if adult cessation programs, including the nicotine patch and nicotine gum, work for children.

Search for other cessation programs suitable for children.

Explore why some youngsters can resist tobacco advertising and marketing schemes that target them.

Seek to discover, in collaboration with NIDA, what genetic factors contribute to tobacco addiction.

Fund epidemiologic research to track children’s smoking patterns for a longer period than ever before.

Pursue better treatments for adults addicted to nicotine.

Extend NCI’s highly successful American Stop Smoking Intervention Study (ASSIST)--a joint program with the American Cancer Society and 17 state health departments--to focus the newest tobacco-control research on populations, such as minority groups, that continue to have a disproportionate rate of tobacco use.

"President Clinton and I see tobacco research not just as a policy priority but as a moral obligation," said Mr. Gore, who often serves as the Administration’s point man on tobacco issues.

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content